Meeting Goals/Purpose

This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.  

The scientific program consists of formal lectures by experts in clinical and basic research, selected slide and poster presentations, forums and case discussions.  The official language of the symposium is English.  Simultaneous translation is not provided

Target Audience

This international symposium is directed primarily towards academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as patient advocates and other appropriate health care professionals. We anticipate 8,000 attendees from more than 80 countries.

Meeting Location - Hybrid

We are very pleased to announce that the San Antonio Breast Cancer Symposium will take place in 2021. The Symposium, which will be held December 7-10, 2021, offers attendees the unique opportunity to participate in person in San Antonio, Texas, or virtually.  The SABCS hybrid meeting will cater to both onsite and virtual meeting attendees and allows the SABCS to switch very quickly to a 100% virtual meeting, if necessary. For the safety of our participants, we have decided to host a hybrid 2021 San Antonio Breast Cancer Symposium. For those attending in-person, SABCS is committed to attendees' safety and will adhere to CDC's safety guidelines and protocols. For attendees who are not able to travel, a virtual option with live web streaming is available. The dates will be December 7-10, 2021 at the Henry B. Gonzalez Convention Center, 900 E. Market Street, San Antonio, TX 78205 USA.

IMPORTANT: As the pandemic continues to evolve, if we are not able to conduct the SABCS in-person, we will convert the entire symposium to a virtual/web stream symposium.

Contact Information

Sharon Hill, Director, Symposia
Mays Cancer Center 
7979 Wurzbach Road, MC 8224 
San Antonio, TX 78229 USA 
Email: sabcs@uthscsa.edu
Phone: 210-450-1550

Preliminary Schedule

Hours subject to change.

Tuesday, December 7
Exhibits 10:00 AM–5:00 PM
Program 8:00 AM–7:00 PM

Wednesday, December 8
Program 8:00 AM–7:00 PM
Exhibits 10:00 AM–5:00 PM

Thursday, December 9
Program 8:00 AM–7:00 PM
Exhibits 10:00 AM–5:00 PM

Friday, December 10
Program 8:00 AM–7:00 PM
Exhibits 10:00 AM–5:00 PM

Executive Committee

Carlos L. Arteaga, UT Southwestern, Harold C. Simmons Cancer Center, Dallas, TX, Co-Director
Angela DeMichele, University of Pennsylvania, Philadelphia, PA
Margaret Foti, American Association for Cancer Research, Philadelphia, PA
David Gius, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Sharon Hill, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX (ex-officio)
Virginia G. Kaklamani, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, Co-Director
Kate Lathrop, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX (ex-officio)
Ruben A. Mesa, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX

Program Planning Committee

Carlos L. Arteaga, UT Southwestern, Harold C. Simmons Cancer Center, Dallas, TX
Banu Arun, UT MD Anderson Cancer Center, Houston, TX
Justin Balko, Vanderbilt University Medical Center, Nashville, TN
Aditya Bardia, Massachusetts General Hospital, Boston, MA
Julia Beaver, FDA, Silver Spring, MD
Melissa Bondy, Stanford Medicine, Stanford, CA
Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC
Gary C. Chamness, Baylor College of Medicine (Retired), Houston, TX (ex-officio)
Angela DeMichele, University of Pennsylvania, Philadelphia, PA
Rebecca Dent, National Cancer Center, Singapore
Matthew Ellis, Baylor College of Medicine, Houston, TX
Margaret Foti, American Association for Cancer Research, Philadelphia, PA
David Gius, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Komal Jhaveri, Memorial Sloan Kettering Cancer Center, New York, NY
Virginia G. Kaklamani, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Seema A. Khan, Northwestern University, Chicago, IL
Tari A. King, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA
Celina Kleer, University of Michigan Medical School, Ann Arbor, MI
Kate Lathrop, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX (ex-officio)
Sherene Loi, Peter MacCallum Cancer Centre, Victoria, Australia
Sibylle Loibl, GBG Forschungs GMBH, Neu-Isenburg, Germany
Eleftherios (Terry) P. Mamounas, Orlando UF Health Cancer Center, Orlando, FL
Rita Nanda, The University of Chicago, Chicago, IL
Ann Partridge, Dana-Farber Cancer Institute, Boston, MA
Charles M. Perou, University of North Carolina, Chapel Hill, NC
Jorge S. Reis- Filho, Memorial Sloan Kettering Cancer Center, New York, NY
Peter Schmid, Bart's Cancer Institute Queen Mary University of London, London, United Kingdom
Zhi-Ming Shao, Fudan University, Shanghai Cancer Center, Shanghai, China
Patty Spears, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
Nicholas Turner, The Royal Marsden Hospital, London, United Kingdom
Alana Welm, University of Utah Huntsman Cancer Institute, Salt Lake City, UT
Wendy Woodward, UT MD Anderson Cancer Center, Houston, TX
Jerry Worden, Alamo Breast Cancer Foundation, San Antonio, TX

Advocate Financial Assistance

Patient advocates wishing to apply for financial assistance for the 2021 Virtual SABCS should contact the Alamo Breast Cancer Foundation for information and an application. Applications are available online. Please see their website for more information and qualifications. Applications must be post-marked by September 1, 2021.

E-mail: sandi@alamobreastcancer.org
Web: www.alamobreastcancer.org

Awards

Susan G. Komen^® Brinker Award for Scientific Distinction

Established by the Susan G. Komen for the Cure in 1992, the Brinker Award for Scientific Distinction recognizes leading scientists for significant work in advancing research concepts and for clinical application in the fields of breast cancer research, screening or treatment. The award is presented to basic and clinical researchers who have made seminal advances in the fight against breast cancer. In addition, the award recognizes scholars for a specific contribution, a consistent pattern of contributions, or leadership in the field that has had a substantial impact on the fight against breast cancer.

The Brinker Award is to be used to further the recipients' activities in breast cancer research. This award has grown in prominence in the breast cancer community and is a marquee award for Komen for the Cure. The recipients of the Brinker Awards will deliver plenary lectures at the 2021 San Antonio Breast Cancer Symposium.

The William L. McGuire Memorial Lectureship

Dr. William L. McGuire, along with Dr. Charles A. Coltman, founded the San Antonio Breast Cancer Symposium in 1977. The William L. McGuire Memorial Lectureship was established in 1992 to commemorate the significant contributions of Dr. McGuire to oncology medicine. His research played a major role in introducing estrogen receptor assays on breast tumor tissue as a guide to treatment decisions for women with breast cancer. Breast cancer patients everywhere now receive these tests.

The lecturer is selected by the SABCS McGuire Award Committee from persons through a nomination process. The selection is based on the following criteria:

• Lecturers are respected figures with an international reputation.

• They have made significant contributions to the field of breast cancer research.

• They are known as skilled presenters.

• They present a topic of high current interest related to the diagnosis and treatment of breast cancer or to the study of its underlying   mechanisms.

AACR Outstanding Investigator Award for Breast Cancer Research, funded by The Breast Cancer Research Foundation

The AACR Outstanding Investigator Award for Breast Cancer Research is presented to an investigator no more than 50 years of age whose novel and significant work that has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer.

AACR Distinguished Lectureship in Breast Cancer Research

The AACR Distinguished Lectureship in Breast Cancer Research has been established to recognize outstanding science that has inspired or has the potential to inspire new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer.

Embargo

Abstracts, with the exception of those withheld for SABCS press conferences, will be released approximately one month prior to the symposium. The abstracts withheld for press will be released at the beginning of the day on which the relevant press conference occurs.

Reporters, producers and editors agree to the embargoes and release times stated on the news releases, the news conference schedule and other materials. Failure to abide by the embargoes will result in suspension of credentials, which will affect attendance at the current and future symposia and ability to receive advance press materials.

By allowing an abstract to be included in the 2020 San Antonio Breast Cancer Symposium media outreach program, the Presenter verifies that the abstract’s contents and its conclusions have not been and will not be published or presented in any form to the public before the start of the actual presentation. This includes, but is not limited to, non-embargoed press releases and interviews required by government agencies. Any release of material and specific non-embargoed information prior to the meeting’s embargo date as set forth by the SABCS press office could result in exclusion from the official SABCS press program.

Proof of Attendance

A statement verifying your participation at the 2021 Virtual Symposium will be emailed to all attendees on Friday, December 10, 2021.

Certificate of Attendance/CME Certificate

Physicians seeking CME credit for this live continuing medical education activity or a Certificate of Attendance must complete the surveys on the 2020 SABCS Mobile App.  Surveys open on December 7, 2021 and close on January 31, 2022. The deadline to complete you session evaluations and post survey is January 31, 2022.